Skip to main content

Table 2 Immunohistochemisty analysis of BTN2A1 and BTN3A1 expression in tumor tissue samples from patients with different grades of glioma

From: B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma

WHO grade

Total Patients (n)

BTN2A1 Expression

Positive Rate (%)

BTN3A1 Expression

Positive Rate (%)

P Value

Positive (n)

Negative (n)

Positive (n)

Negative (n)

II

7

2

5

29

2

5

29

 

III

5

1

4

20

2

3

40

 > 0.05

IV

14

6

8

43

7

7

50